Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Phase I/II Study of Silmitasertib (CX-4945) in Combination with Chemotherapy in Children and Young Adults with Relapsed Refractory Solid Tumors

Disease Sites:

Not Available

Staging:

Phase I/II

Age Group:

Both

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Not Available

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

01-06-2026

Trial Type:

Treatment

Protocol ID:

VICCPED24526

National Clinical Trial ID:

NCT06541262

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available